Premium
Letter: should colectomy be the end‐point to evaluate the effectiveness of drug therapies in severe ulcerative colitis?
Author(s) -
Domènech E.,
Gisbert J. P.
Publication year - 2013
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.12095
Subject(s) - medicine , ciclosporin , infliximab , ulcerative colitis , colectomy , population , inflammatory bowel disease , refractory (planetary science) , disease , surgery , transplantation , physics , environmental health , astrobiology